NEOANTIGEN VACCINE CLINICAL TRIALS

NIH RePORTER · NIH · N01 · $5,794,341 · view on reporter.nih.gov ↗

Abstract

This initiative will demonstrate the feasibility of NCI support for personalized neoantigen vaccine clinical trials.

Key facts

NIH application ID
10281326
Project number
75N91019D00024-0-759102000018-1
Recipient
LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator
ETHAN DMITROVSKY
Activity code
N01
Funding institute
NIH
Fiscal year
2020
Award amount
$5,794,341
Award type
—
Project period
2020-09-25 → 2025-09-24